Vectorious Medical Technologies is rated 3 out of 5 in the category medical devices. Read and write reviews about Vectorious Medical Technologies. Vectorious Medical Technologies developed the V-LAP, a revolutionary in-heart microcomputer - enabling optimal treatment for heart disease patients, increasing their quality of life and life expectancy. The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. It monitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration. Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020.
Address
24 Raul Wallenberg
Company size
11-50 employees
Headquarters
Tel Aviv, Tel aviv